Management

Dr. Hamdy is Chief Medical Officer of Curis, joining the Company in May 2025. Prior to joining Curis, he served as CEO and Chairman of the board of directors of Vincerx Pharma, Inc.  Prior to Vincerx, Dr. Hamdy co-founded Acerta Pharma, LLC, and served as its CEO and CMO. Before Acerta, Dr. Hamdy was CMO of Pharmacyclics, Inc.  Dr. Hamdy is an Adjunct Professor at University of California Santa Cruz Department of Biomolecular engineering and is a member of the Dean’s Council of the Jack Baskin School of Engineering at the University of California, Santa Cruz. Dr. Hamdy received his MBBCH from the KasrAlainy School of Medicine at the University of Cairo, Egypt.